Literature DB >> 16160169

Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.

Vasiliy P Mishin1, Dmitri Novikov, Frederick G Hayden, Larisa V Gubareva.   

Abstract

Inhibition of neuraminidase (NA) activity prevents release of progeny virions from influenza-infected cells and removal of neuraminic (sialic) acid moieties from glycans attached to hemagglutinin (HA). Neuraminic acid moieties situated near the HA receptor-binding site can reduce the efficiency of virus binding and decrease viral dependence on NA activity for replication. With the use of reverse genetics technique, we investigated the effect of glycans attached at Asn 94a, 129, and 163 on the virus susceptibility to NA inhibitors in MDCK cells and demonstrated that the glycan attached at Asn 163 plays a dominant role in compensation for the loss of NA activity.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16160169      PMCID： PMC1211522          DOI： 10.1128/JVI.79.19.12416-12424.2005

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  50 in total

1.  Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety.

Authors:  M Ohuchi; R Ohuchi; A Feldmann; H D Klenk
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Studies on the molecular basis for loss of the ability of recent influenza A (H1N1) virus strains to agglutinate chicken erythrocytes.

Authors:  T Morishita; E Nobusawa; K Nakajima; S Nakajima
Journal:  J Gen Virol       Date:  1996-10       Impact factor: 3.891

3.  Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.

Authors:  J L McKimm-Breschkin; T J Blick; A Sahasrabudhe; T Tiong; D Marshall; G J Hart; R C Bethell; C R Penn
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species.

Authors:  T Ito; Y Suzuki; L Mitnaul; A Vines; H Kida; Y Kawaoka
Journal:  Virology       Date:  1997-01-20       Impact factor: 3.616

5.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

6.  Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en.

Authors:  L V Gubareva; R Bethell; G J Hart; K G Murti; C R Penn; R G Webster
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  The glycosylation of the influenza A virus hemagglutinin by mammalian cells. A site-specific study.

Authors:  S Y Mir-Shekari; D A Ashford; D J Harvey; R A Dwek; I T Schulze
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

8.  Two evolutionary strategies of influenza viruses to escape host non-specific inhibitors: alteration of hemagglutinin or neuraminidase specificity.

Authors:  U Gimsa; I Grötzinger; J Gimsa
Journal:  Virus Res       Date:  1996-06       Impact factor: 3.303

9.  Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.

Authors:  P Palese; R W Compans
Journal:  J Gen Virol       Date:  1976-10       Impact factor: 3.891

10.  Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding.

Authors:  C Liu; M C Eichelberger; R W Compans; G M Air
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103
View more
  29 in total

1.  Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.

Authors:  Katja Bauer; Ralf Dürrwald; Michael Schlegel; Kathrin Pfarr; Dominik Topf; Nadine Wiesener; Hans-Martin Dahse; Peter Wutzler; Michaela Schmidtke
Journal:  Med Microbiol Immunol       Date:  2011-06-19       Impact factor: 3.402

2.  Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors.

Authors:  Larisa Mochalova; Rick Bright; Xiyan Xu; Elena Korchagina; Alexander Chinarev; Nicolai Bovin; Alexander Klimov
Journal:  Glycoconj J       Date:  2010-03-02       Impact factor: 2.916

3.  Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells.

Authors:  Jeremy C Jones; Elizabeth A Turpin; Hermann Bultmann; Curtis R Brandt; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

4.  How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example.

Authors:  Andreas Handel; Victoria Akin; Sergei S Pilyugin; Veronika Zarnitsyna; Rustom Antia
Journal:  J R Soc Interface       Date:  2014-01-15       Impact factor: 4.118

5.  Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2.

Authors:  Mohamed Rajik; Fatemeh Jahanshiri; Abdul Rahman Omar; Aini Ideris; Sharifah Syed Hassan; Khatijah Yusoff
Journal:  Virol J       Date:  2009-06-05       Impact factor: 4.099

6.  Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.

Authors:  Irina V Alymova; Garry Taylor; Vasiliy P Mishin; Makiko Watanabe; K Gopal Murti; Kelli Boyd; Pooran Chand; Y Sudhakara Babu; Allen Portner
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

7.  Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level.

Authors:  Jean François Rossignol; Simone La Frazia; Lucia Chiappa; Alessandra Ciucci; M Gabriella Santoro
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

8.  Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.

Authors:  Donald F Smee; Kevin W Bailey; Min-Hui Wong; Barry R O'Keefe; Kirk R Gustafson; Vasiliy P Mishin; Larisa V Gubareva
Journal:  Antiviral Res       Date:  2008-07-02       Impact factor: 5.970

9.  Molecular analysis of hemagglutinin, neuraminidase, matrix genes provide insight into the genetic diversity of seasonal H3N2 human influenza a viruses in Bangladesh during July-August, 2012.

Authors:  Mukesh Jain; Sohidul Islam; A S M Zisanur Rahman; Sharmin Akhtar; Kazi Nadim Hasan; Gias Uddin Ahsan; Abdul Khaleque; Maqsud Hossain
Journal:  Virusdisease       Date:  2018-02-01

10.  Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.

Authors:  Gallen B Triana-Baltzer; Larisa V Gubareva; Alexander I Klimov; David F Wurtman; Ronald B Moss; Maria Hedlund; Jeffrey L Larson; Robert B Belshe; Fang Fang
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.